CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Aspirindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00466154
NCT00466154N/ACompleted
CompareCT.gov

The Effect of Serum LDL Lowering on Aspirin Resistance

Ziv Hospital·interventional·Posted Apr 27, 2007·Updated Feb 20, 2013

In Brief

A clinical study evaluating Aspirin for Aspirin Resistance and Hypercholesterolemia. Completed, across 1 site.

Detailed Summary

Aspirin resistance is the persistent platelet activation, demonstrated by platelet function tests (1). The hypothesis is that:LDL lowering by statin in patients with aspirin resistance can improve the effect of aspirin due to the potential decreasing of cholesterol content in the platelet membranes. Patients and methods:Forty hypercholesterolemic patients with aspirin resistance after 5 days of treatment with aspirin and high LDL and triglycerides\<300 mg/dL, will be enrolled. Ten healthy volunteers will be the control group.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAspirin Resistance, Hypercholesterolemia
CountriesIsrael
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 27, 2007
Enrollment StartJul 1, 2005
Study CompletionJan 1, 2007
TodayJul 2, 2026
Posted 19.2 years ago

Interventions

Aspirindrug